Type 1 Diabetes clinical trials

210 recruiting studies in the US for type 1 diabetes, an autoimmune condition where the body makes little or no insulin.

Type 1 diabetes research leans toward technology and care studies — automated insulin delivery, continuous glucose monitors, exercise and education — along with a smaller set of Phase 2 trials aiming to protect insulin-producing cells. Some studies enroll people recently diagnosed, while others focus on long-standing diabetes. Many include children and teens.

Top locations

By phase

Showing 40 of 210 studies

RecruitingPhase 1 / Phase 2NCT06524960

Denosumab for Type 1 Diabetes

Sponsor: City of Hope Medical Center

Birmingham, AL · Duarte, CA · Indianapolis, IN

RecruitingPhase not listedNCT02734277

Type 1 Diabetes Extension Study

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

San Francisco, CA · Stanford, CA · Aurora, CO · +9 more sites

Related conditions

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.